Filing Details

Accession Number:
0001385508-23-000007
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-05 16:56:03
Reporting Period:
2023-01-05
Accepted Time:
2023-01-05 16:56:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1385508 Opiant Pharmaceuticals Inc. OPNT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1358116 Phil Skolnick C/O Opiant Pharmaceuticals, Inc.
233 Wilshire Blvd., Suite 400
Santa Monica CA 90401
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-01-05 1,421 $20.20 22,397 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.